selected publications
- Use of a novel endoscopic overtube with bilateral tool channels for endoscopic resection of experimental lesions and repair of intestinal defects in the right colon: preclinical trial. Surgical endoscopy. 2022 Academic Article GET IT
-
Use of an endoscopic flexible grasper as a traction tool for excision of polyps: preclinical trial.
Scientific reports.
2021
Academic Article
GET IT
Times cited: 1 - Novel percutaneous access to the large intestine using a double-balloon endoluminal platform for excision of a large polyp. Endoscopy. 2021 Academic Article GET IT
-
Use of endoscopic sleeve to achieve full-thickness endoscopic resection of malignant polyp under direct vision.
Endoscopy.
2021
Academic Article
GET IT
Times cited: 1 - Managing Stricturing Crohn's Disease: Resect? Strictureplasty? Dilate?. Journal of laparoendoscopic & advanced surgical techniques. Part A. 2021 Academic Article GET IT
-
Endoscopic submucosal dissection of large polyps in the right colon using an endoscopic snare with a double-balloon endolumenal interventional platform: an ex vivo study in a porcine colorectal model.
Surgical endoscopy.
2020
Academic Article
GET IT
Times cited: 5 - Postoperative Considerations in Inflammatory Bowel Disease. The Surgical clinics of North America. 2019 Review GET IT
-
CD4+ Th1 to the rescue in HER-2+ breast cancer.
Oncoimmunology.
2018
Academic Article
GET IT
Times cited: 3 -
Oncodriver inhibition and CD4+ Th1 cytokines cooperate through Stat1 activation to induce tumor senescence and apoptosis in HER2+ and triple negative breast cancer: implications for combining immune and targeted therapies.
Oncotarget.
2018
Academic Article
GET IT
Times cited: 18 -
Dendritic Cell Vaccination Enhances Immune Responses and Induces Regression of HER2pos DCIS Independent of Route: Results of Randomized Selection Design Trial.
Clinical cancer research : an official journal of the American Association for Cancer Research.
2016
Academic Article
GET IT
Times cited: 93 -
Loss of Anti-HER-3 CD4+ T-Helper Type 1 Immunity Occurs in Breast Tumorigenesis and is Negatively Associated with Outcomes.
Annals of surgical oncology.
2016
Academic Article
GET IT
Times cited: 13 -
Addition of anti-estrogen therapy to anti-HER2 dendritic cell vaccination improves regional nodal immune response and pathologic complete response rate in patients with ERpos/HER2pos early breast cancer.
Oncoimmunology.
2016
Academic Article
GET IT
Times cited: 22 -
Multimodality Therapy Improves Survival in Resected Early Stage Gastric Cancer in the United States.
Annals of surgical oncology.
2016
Academic Article
GET IT
Times cited: 17 -
Multimodality Treatment of T4 Gastric Cancer in the United States: Utilization Trends and Impact on Survival.
Annals of surgical oncology.
2015
Academic Article
GET IT
Times cited: 14 -
Anti-HER2 CD4(+) T-helper type 1 response is a novel immune correlate to pathologic response following neoadjuvant therapy in HER2-positive breast cancer.
Breast cancer research : BCR.
2015
Academic Article
GET IT
Times cited: 53 -
Optimizing dendritic cell-based approaches for cancer immunotherapy.
The Yale journal of biology and medicine.
2014
Review
GET IT
Times cited: 46